CIK

BIOLOGICAL7 trials

Conditions

Adoptive ImmunotherapyAdvanced Liver CancerAdvanced Milignant GliomasCytokine-Induced Killer CellsGastric CancerLiver CancerLung AdenocarcinomaMilignant Gliomas

Phase 1

Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

CompletedNCT01894373

Chinese PLA General HospitalAdoptive Immunotherapy, Psoriasis

Start: 2015-06-30End: 2017-06-30Target: 10Updated: 2018-05-17

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Not yet recruitingNCT02494804

The First People's Hospital of ChangzhouCytokine-Induced Killer Cells, Milignant Gliomas

Start: 2015-07-31End: 2030-07-31Target: 80Updated: 2015-07-10

Safety and Efficacy of γδ T Cell Against Gastric Cancer

NCT02585908

Beijing Doing Biomedical Co., Ltd.Gastric Cancer

Start: 2019-12-31End: 2022-12-31Target: 120Updated: 2019-11-13

Phase 2

Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma

TerminatedNCT02621333

Henan Cancer HospitalLung Adenocarcinoma

Start: 2015-10-31End: 2018-09-30Updated: 2021-05-12

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

NCT03146637

Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Advanced Liver Cancer

Start: 2017-05-01End: 2021-01-28Target: 80Updated: 2021-02-01

Phase 3

Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC

NCT02568748

Sherief Abd-ElsalamLiver Cancer

Start: 2015-10-31End: 2019-10-31Target: 20Updated: 2017-04-27

Phase 4

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Not yet recruitingNCT02496988

The First People's Hospital of ChangzhouAdvanced Milignant Gliomas, Cytokine-Induced Killer Cells

Start: 2015-07-31End: 2030-07-31Target: 120Updated: 2015-07-14

Related Papers

Efficacy and safety of MUC1 targeted CIK cells for the treatment of advanced liver cancer.

Journal of Clinical Oncology2021-05-203 citations

Restoration of CD3<sup>+</sup>CD56<sup>+</sup> cell level improves skin lesions in severe psoriasis: A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells.

2018-08-095 citations